[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f1lfovfyaathyi":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":4,"products":23,"patents":36,"exclusivities":37,"paragraphIv":38,"catalysts":40},"DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%","DILTIAZEM HYDROCHLORIDE","EXELA PHARMA","exela-pharma",[20],"215252","none",2,[24,32],{"key":25,"applNo":20,"productNo":26,"dosageForm":27,"route":28,"strength":29,"approvalDate":30,"rld":4,"teCode":12,"type":31,"loe":12,"basis":21,"carveOutPossible":13},"215252-001","001","SOLUTION","INTRAVENOUS","125MG\u002F125ML (1MG\u002FML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2021-10-28","DISCN",{"key":33,"applNo":20,"productNo":34,"dosageForm":27,"route":28,"strength":35,"approvalDate":30,"rld":4,"teCode":12,"type":31,"loe":12,"basis":21,"carveOutPossible":13},"215252-002","002","250MG\u002F250ML (1MG\u002FML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",[],[],{"asOf":12,"firstFiled":12,"entries":39},[],[]]